Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can family support ease the burden of advanced lung cancer?

NCT ID NCT07490639

First seen Mar 30, 2026 · Last updated Jun 19, 2026 · Updated 10 times

Summary

This study tested whether a family-supported palliative care program could improve quality of life and emotional well-being in 110 people with advanced lung cancer. Participants were randomly assigned to either the family-supported program or standard nursing care for 8 weeks. The program included education, caregiver training, and emotional support, aiming to reduce anxiety and help with decision-making.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Shanxi Province Cancer Hospital

    Taiyuan, Shanxi, 030013, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Family-Supported Palliative Care (behavioral intervention)

What this could lead to

If successful, this approach could provide a structured way to improve quality of life and emotional well-being for people with advanced lung cancer through family involvement.

What could go wrong

This is a small, single-center study with no blinding, so results may not apply broadly. The intervention is behavioral, not a drug, so benefits may be modest and hard to replicate.

Conditions

The condition(s) this trial relates to.

lung carcinoma lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.